Development and Validation of a Nomogram Model for Predicting the Risk of Readmission in Patients with Heart Failure with Reduced Ejection Fraction within 1 Year

被引:5
|
作者
Hu, Yue [1 ]
Wang, Xiaotong [2 ]
Xiao, Shengjue [3 ]
Huan, Chunyan [2 ]
Wu, Huimin [1 ]
Xu, Tao [2 ]
Guo, Minjia [2 ]
Zhu, Hong [2 ]
Pan, Defeng [2 ]
机构
[1] Xuzhou Med Univ, Dept Gen Practice, Affiliated Hosp, Xuzhou 221004, Jiangsu, Peoples R China
[2] Xuzhou Med Univ, Dept Cardiol, Affiliated Hosp, Xuzhou 221004, Jiangsu, Peoples R China
[3] Southeast Univ, Zhongda Hosp, Sch Med, Dept Cardiol, 87 Dingjiaqiao, Nanjing 210009, Jiangsu, Peoples R China
关键词
OUTCOMES; EPIDEMIOLOGY; MORTALITY; AGE; ASSOCIATION; DYSFUNCTION; MECHANISMS; CARDIOLOGY; IMPACT;
D O I
10.1155/2022/4143173
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The high incidence of readmission for patients with reduced ejection fraction heart failure (HFrEF) can seriously affect the prognosis. In this study, we aimed to build a simple predictive model to predict the risk of heart failure (HF) readmission in patients with HFrEF within one year of discharge from the hospital. This retrospective study enrolled patients with HFrEF evaluated in the Heart Failure Center of the Affiliated Hospital of Xuzhou Medical University from January 2018 to December 2020. The patients were allocated into the readmission or nonreadmission group, according to whether HF readmission occurred within 1 year of hospital discharge. Subsequently, all patients were randomly divided into training and validation sets in a 7 : 3 ratio. A nomogram was established according to the results of univariate and multivariate logistic regression analysis. Finally, the area under the receiver operating characteristic curve (AUC-ROC), calibration plot, and decision curve analysis (DCA) were used to validate the nomogram. Independent risk factors for HF readmission of patients with HFrEF within 1 year of hospital discharge were as follows: age, body mass index, systolic blood pressure, diabetes mellitus, left ventricular ejection fraction, and angiotensin receptor-neprilysin inhibitors. The AUC-ROC of the training and validation sets were 0.833 (95% confidence interval (CI): 0.793-0.866) and 0.794 (95% CI: 0.727-0.852), respectively, which have an excellent distinguishing ability. The predicted and observed values of the calibration curve also showed good consistency. DCA also confirmed that the nomogram had good clinical value. In conclusion, we constructed an accurate and straightforward nomogram model for predicting the 1-year HF readmission risk in patients with HFrEF. This nomogram can guide early clinical intervention and improve patient prognosis.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] 30-Day Readmission And Outcomes In Patients With Physical Disabilities And Coexisting Heart Failure With Reduced Ejection Fraction Versus Heart Failure With Preserved Ejection Fraction
    Udongwo, Ndausung
    Weze, Kelechi
    Antia, Akanimo
    Abe, Temidayo
    Adeniyi, Adeyinka
    Zhuo, David
    Taha, Yasir
    Onwuanyi, Anekwe
    Echols, Melvin
    Heaton, Joseph
    JOURNAL OF CARDIAC FAILURE, 2025, 31 (01)
  • [22] 30 DAY READMISSION AND OUTCOMES IN HEART FAILURE WITH REDUCED EJECTION FRACTION VS HEART FAILURE WITH PRESERVED EJECTION FRACTION IN PATIENTS WITH COEXISTING OBSTRUCTIVE SLEEP APNEA
    Johal, Anmol
    Imburgio, Steven
    Dandu, Sowmya
    Akhlaq, Hira
    Klei, Lauren
    Mararenko, Anton
    Alshami, Abbas
    Patel, Palak
    Upadhyaya, Vandan D.
    Arcidiacono, Anne M.
    Udongwo, Ndausung
    Hossain, Mohammad
    Asif, Arif
    Heaton, Joseph
    Schoenfeld, Matthew
    Sealove, Brett
    Almendral, Jesus G.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 652 - 652
  • [23] Risk Factors for All-Cause Readmission after Heart Failure Admission in Patients with Preserved or Reduced Ejection Fraction
    Siegfried, Jonathan S.
    Sagiv, Ofer
    Berkowitz, Eric
    Takhalov, Yuri
    Eltom, Alaeldin
    Patel, Suhash
    Benjamin, Ralph
    Alemu, Benyam
    Osahan, Deepinder
    Siller, Jennifer
    Ullman, Jennifer
    Panagopoulos, Georgia
    Messineo, Frank
    Coplan, Neil L.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2013, 61 (03) : 659 - 659
  • [24] Determinants of ejection fraction improvement in heart failure patients with reduced ejection fraction
    Liu, Dan
    Hu, Kai
    Schregelmann, Lena
    Hammel, Clara
    Lengenfelder, Bjorn Daniel
    Ertl, Georg
    Frantz, Stefan
    Nordbeck, Peter
    ESC HEART FAILURE, 2023, 10 (02): : 1358 - 1371
  • [25] Dapagliflozin for patients with heart failure and reduced ejection fraction
    Ferry, Abigail
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2022, 35 (09): : 51 - 53
  • [26] Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
    McMurray, J. J. V.
    Solomon, S. D.
    Inzucchi, S. E.
    Kober, L.
    Kosiborod, M. N.
    Martinez, F. A.
    Ponikowski, P.
    Sabatine, M. S.
    Anand, I. S.
    Belohlavek, J.
    Bohm, M.
    Chiang, C. -E.
    Chopra, V. K.
    de Boer, R. A.
    Desai, A. S.
    Diez, M.
    Drozdz, J.
    Dukat, A.
    Ge, J.
    Howlett, J. G.
    Katova, T.
    Kitakaze, M.
    Ljungman, C. E. A.
    Merkely, B.
    Nicolau, J. C.
    O'Meara, E.
    Petrie, M. C.
    Vinh, P. N.
    Schou, M.
    Tereshchenko, S.
    Verma, S.
    Held, C.
    DeMets, D. L.
    Docherty, K. F.
    Jhund, P. S.
    Bengtsson, O.
    Sjostrand, M.
    Langkilde, A. -M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (21): : 1995 - 2008
  • [27] Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction
    Armstrong, Paul W.
    Pieske, Burkert
    Anstrom, Kevin J.
    Ezekowitz, Justin
    Hernandez, Adrian F.
    Butler, Javed
    Lam, Carolyn S. P.
    Ponikowski, Piotr
    Voors, Adriaan A.
    Jia, Gang
    McNulty, Steven E.
    Patel, Mahesh J.
    Roessig, Lothar
    Koglin, Joerg
    O'Connor, Christopher M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (20): : 1883 - 1893
  • [28] Dapagliflozin in patients with heart failure and reduced ejection fraction
    Giorgio Colombo
    Rosa Casella
    Alessia Cazzaniga
    Chiara Casiraghi
    Internal and Emergency Medicine, 2020, 15 : 515 - 517
  • [29] Hypertension in Patients with Heart Failure with Reduced Ejection Fraction
    Volpe, Massimo
    Santolamazza, Caterina
    Tocci, Giuliano
    CURRENT CARDIOLOGY REPORTS, 2016, 18 (12)
  • [30] Cells in Patients with Heart Failure with Reduced Ejection Fraction
    Lopes, Jose
    Teixeira, Manuel
    Cavalcante, Suiane
    Gouveia, Marisol
    Duarte, Ana
    Ferreira, Miriam
    Simoes, Maria I.
    Conceicao, Maria
    Ribeiro, Ilda P.
    Goncalves, Ana C.
    Schmidt, Cristine
    de Jesus, Bruno Bernardes
    Almeida, Ramiro
    Viamonte, Sofia
    Santos, Mario
    Ribeiro, Fernando
    ARCHIVES OF MEDICAL RESEARCH, 2022, 53 (03) : 289 - 295